Clavis Pharma: Clinical Trials

7 trials sponsored by Clavis Pharma, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

7 completed. 7 Phase 2, 2 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 27Completed 7
Phase 12Completed 2

Follow Clavis Pharma: new trials by email

Trials (filtered) newest first · largest first

All 7 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Study of Elacytarabine (CP-4055) Plus Idarubicin as Second Course Remission-Induction Therapy in Patients With Acute Myeloid Leukaemia
Elacytarabine plus idarubicin - Acute Myeloid Leukemia
Phase 2CompletedClavis Pharma512009-12-012013-09-27
A Study of CP-4126 in Patients With Advanced Pancreatic Cancer
IV CP-4126 - Advanced Adenocarcinoma of Pancreas
Phase 2CompletedClavis Pharma212009-04-012012-02-10
A Phase I/II Study of CP-4055 in Patients With Platinum Resistant Ovarian Cancer
CP-4055 - Ovarian Cancer
Phase 1 / Phase 2CompletedClavis Pharma282008-04-012013-09-13
A Phase II Study of CP-4055 as Second Line Therapy in Patients With Advanced Colorectal Cancer
CP-4055 - Advanced Colorectal Cancer, Colorectal Cancer
Phase 2CompletedClavis Pharma162007-05-012009-06-04
Multicentre, Dose Finding, Ph II,CP-4055 in Comb. With Sorafenib - Patients With Metastatic Malignant Melanoma
CP-4055, Sorafenib (Nexavar) - Malignant Melanoma
Phase 2CompletedClavis Pharma182007-03-012013-09-12
A Phase I/II Study of CP-4055 in Patients With Refractory/Relapsed Hematologic Malignancies
CP-4055 - Hematologic Malignancies, AML
Phase 1 / Phase 2CompletedClavis Pharma1532006-05-012013-09-18
Clinical Study of Previously Untreated Patients With Malignant Melanoma
CP-4055 (ELACYT) - Malignant Melanoma, Neoplasm Metastasis
Phase 2CompletedClavis Pharma422005-09-012007-07-10

Conditions studied

Neoplasms (5)  ·  Neoplasm Metastasis (3)  ·  Melanoma (2)  ·  Colorectal Neoplasms (1)  ·  Hematologic Neoplasms (1)  ·  Leukemia (1)  ·  Leukemia, Myeloid, Acute (1)  ·  Ovarian Neoplasms (1)  ·  Recurrence (1)

Interventions

5'-oleoyl cytarabine (6)  ·  CP 4126 (1)  ·  Idarubicin (1)  ·  Sorafenib (1)

Countries

Norway (5)  ·  United States (4)  ·  Belgium (2)  ·  France (2)  ·  Germany (2)  ·  Italy (2)  ·  Sweden (2)  ·  United Kingdom (2)

Top investigators

David A Rizzieri, MD (1)  ·  Francis J Giles, MD (1)  ·  Jim Cassidy, MBChB, MD (1)  ·  Sandro Pignata, MD (1)  ·  Svein Dueland, MD (1)  ·  Svein Dueland, MD, Ph.D (1)